⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,839.74
−0.20%
FTSE ADX
9,833.27
+0.51%
TASI
10,058.32
−0.65%
QE Index
8,556.66
−0.88%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
166,083.17
+0.07%
DFM:EMIRATESNBD
AED 31.54
+0.13%
ADX:IHC
AED 357.20
+1.48%
SAU:2222
SAR 25.78
−0.08%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 301.00
+0.51%
Gold
$4,132.13
−0.21%
Brent
$110.43
+1.11%
BTC
$81,602.24
−0.29%
ETH
$2,393.43
−0.49%
DFM General
5,839.74
−0.20%
FTSE ADX
9,833.27
+0.51%
TASI
10,058.32
−0.65%
QE Index
8,556.66
−0.88%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
166,083.17
+0.07%
DFM:EMIRATESNBD
AED 31.54
+0.13%
ADX:IHC
AED 357.20
+1.48%
SAU:2222
SAR 25.78
−0.08%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 301.00
+0.51%
Gold
$4,132.13
−0.21%
Brent
$110.43
+1.11%
BTC
$81,602.24
−0.29%
ETH
$2,393.43
−0.49%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Eli Lilly and Co · News · TradingHolo
Markets
›
United States
› NYSE
› LLY
E
Eli Lilly and Co
NYSE:LLY
Healthcare
CBOE:SPESG
NASDAQ:NQUSLG
$1,240.34
−1.33%
At close
At close · Tue 20 Oct · ≈
AED 4,555.15
· Market cap
$1.17T
· Next earnings
Thu 29 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
LLY news
Headlines tagged to this company
RE
Eli Lilly's weight-loss pill wins backing in Europe
Reuters · 4 d ago
RE
S&P 500 near flat as traders shift out of risky AI bets
Reuters · 5 d ago
MA
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
MarketWatch · 5 d ago
SE
Eli Lilly's Omvoh boosted by new ulcerative colitis, Crohn's data
Seeking Alpha · 5 d ago
SE
GLP-1s are linked to lower psychiatric hospitalizations: study
Seeking Alpha · 5 d ago
PR
Lilly confirms date and conference call for third-quarter 2026 financial results announcement
PR Newswire · 5 d ago
RE
AstraZeneca strikes $40 million AI drug discovery deal with insitro
Reuters · 5 d ago
MI
Our central mission must be patient-centric innovation: JP Nadda
Mint · 5 d ago
DO
Lilly, Merck, AbbVie Stocks Surge. Why Healthcare Is Rallying Today. — Barrons.com
Dow Jones Newswires · 5 d ago
DO
Here's What to Buy After Hot CPI Puts an October Fed Rate Hike Back on the Table — Barrons.com
Dow Jones Newswires · 6 d ago
SE
Stocks with rising earnings estimates despite YTD share-price declines
Seeking Alpha · 6 d ago
RE
Pharma sector doubles down on AI to slash costs, timelines
Reuters · 6 d ago
DP
GLP-1 Drugs May Slow Aging By Upto Four Years, Early Research Suggest
dpa-AFX · 7 d ago
ST
Prelude Therapeutics Teams Up With Lilly To Test Experimental Breast Cancer Drug In Phase 1 Trial
Stocktwits · 7 d ago
SE
Walmart expands free drug coverage, adds healthcare benefits for workers
Seeking Alpha · 7 d ago
RE
Prelude Announces Clinical Trial Collaboration And Supply Agreement With Lilly To Evaluate KAT6A Selective Degrader PRT13722 In Combination With Verzenio® And Inluriyo® In Patients With HR+/HER2- Breast Cancer
Reuters · 7 d ago
SE
AbbVie, Eli Lilly among mega-cap healthcare stocks with A+ profitability grades
Seeking Alpha · 7 d ago
GL
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
GlobeNewswire · 7 d ago
SE
Roche signs $1.16B obesity drug deal with China’s Rona Therapeutics
Seeking Alpha · 7 d ago
DO
Eli Lilly Price Target Maintained With a $1500.00/Share by RBC Capital
Dow Jones Newswires · 8 d ago
← Previous
More news →